Refining prognosis in non-small-cell lung cancer.
作者信息
Sun Zhifu, Yang Ping
出版信息
N Engl J Med. 2007 Jan 11;356(2):189-90; author reply 190-1. doi: 10.1056/NEJMc062409.
PMID:17215540
Abstract
摘要
相似文献
1
Refining prognosis in non-small-cell lung cancer.
N Engl J Med. 2007 Jan 11;356(2):189-90; author reply 190-1. doi: 10.1056/NEJMc062409.
2
Refining prognosis in non-small-cell lung cancer.
N Engl J Med. 2007 Jan 11;356(2):190; author reply 190-1.
3
Refining prognosis in non-small-cell lung cancer.
N Engl J Med. 2007 Jan 11;356(2):190; author reply 190-1.
4
Recurrent chromosomal imbalances in nonsmall cell lung carcinoma: the association between 1q amplification and tumor recurrence.
Cancer. 2004 May 1;100(9):1918-27. doi: 10.1002/cncr.20190.
5
Five-gene signature in non-small-cell lung cancer.
N Engl J Med. 2007 Apr 12;356(15):1582; author reply 1583.
6
[Flow cytometric analysis of the DNA content of resected non-small cell lung cancer with reference to long-term follow-up].
Gan To Kagaku Ryoho. 1996 Jun;23 Suppl 2:130-4.
7
DNA methylation in lung cancer.
N Engl J Med. 2008 Jun 5;358(23):2513; author reply 2514.
8
Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.
Clin Cancer Res. 2010 Jan 15;16(2):610-9. doi: 10.1158/1078-0432.CCR-09-2638. Epub 2010 Jan 12.
9
The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
Cancer Lett. 2008 Feb 8;259(2):177-85. doi: 10.1016/j.canlet.2007.10.013. Epub 2007 Nov 26.
10
Protein expression profiles of non-small cell lung carcinomas: correlation with histological subtype.
Anticancer Res. 2002 Jul-Aug;22(4):2321-4.
引用本文的文献
1
Tumor-derived exosomal miR-19b-3p facilitates M2 macrophage polarization and exosomal LINC00273 secretion to promote lung adenocarcinoma metastasis via Hippo pathway.
Clin Transl Med. 2021 Sep;11(9):e478. doi: 10.1002/ctm2.478.
Zotero 插件